Expression of chemerin receptor genes CMKLR1, GPR1 or CCRL2 is associated with longer survival in ovarian cancer, breast cancer and non-small-cell lung cancer (NSCLC) [15]. This evidence concerns the gene CCRL2 and non-small cell lung carcinoma.